UNSPSC 51372014: Metopon

This classification denotes an opioid receptor agonist with the molecular formula C18H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 94XZ1CC69D, chemically known as 4,5-alpha-epoxy-3-hydroxy-5,17-diethylmorphinan-6-one but generally known as metopon, which bears US NIH Compound Identifier 5359353. European Medicines Agency schedules Metopon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08909MIG. The term METOPON is an International Non-Proprietary Name.

UNSPSC 51372014 Metopon is a Commodity code capturing pharmaceutical products—specifically controlled and non-controlled drugs—that state and local governments procure for public health, emergency response, and community health initiatives. Recent opportunities show state and local buyers acquiring naloxone and drug deactivation systems for harm reduction programs, generic multi-source pharmaceuticals and over-the-counter products for health systems and cooperative purchasing networks, and direct-to-manufacturer prescription fulfillment capabilities to optimize pharmacy benefit management. State agencies, counties, and cooperative purchasing alliances (including multi-state groups) issue solicitations under this code. Issuing bodies range from individual county health departments to state health and human services commissions to multi-state cooperative purchasing organizations serving multiple jurisdictions simultaneously.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the county community health building, due July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather market intelligence on vendors' capacity to establish direct-to-manufacturer prescription programs for the state's pharmacy benefit initiative. The Minnesota Department of Administration's Office of State Procurement, administering the multistate cooperative purchasing vehicle MMCAP, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026. Vendors must comply with cGMP and DSCSA requirements, maintain authorized wholesaler relationships, and carry specified insurance coverages including commercial general liability of $5,000,000 per occurrence.